logo

For the Inventor, By the Inventor

Hyderabad Telangana, India

Saidulu Mattapally

This inventor holds 4 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2016-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saidulu Mattapally. Retrieved from https://idiyas.com/inventor/saidulu-mattapally

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal4 out of 2,130 
 
Council of Scientific and Industrial Research
 patents

Years Active: 2016-2017

Loading Chart...
4 patents (USPTO):Explore Patents
1. 9562045 - Process for preparation of indolizine based derivatives as potential phosphodiestrase 3 (PDE3) inhibitors (2017-02-07),
2. 9505760 - Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof (2016-11-29),
3. 9249139 - Indolizinone based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof (2016-02-02),
4. 9242982 - Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof (2016-01-26),

Title: Innovations by Saidulu Mattapally

Introduction

Saidulu Mattapally is an accomplished inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of phosphodiesterase inhibitors. With a total of 4 patents to his name, his work has the potential to impact various therapeutic areas.

Latest Patents

One of his latest patents is titled "Process for preparation of indolizine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors." This invention provides compounds of general formula 1 that are useful as potential PDE3 inhibitory agents. The derivatives can be employed as therapeutics in both human and veterinary medicine, targeting diseases such as heart failure, dilated cardiomyopathy, cancer, and obstructive pulmonary diseases.

Another notable patent is "Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof." Similar to his previous work, this invention also offers compounds of formula 1 as potential PDE3 inhibitory agents, with applications in treating various medical conditions.

Career Highlights

Saidulu Mattapally is currently associated with the Council of Scientific and Industrial Research, where he continues to innovate and contribute to scientific advancements. His work is characterized by a strong focus on developing new therapeutic agents that can improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Budde Mahendar and Mettu Ravinder, enhancing the scope and impact of his research efforts.

Conclusion

Saidulu Mattapally's contributions to the field of medicinal chemistry through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work holds promise for the treatment of critical diseases, showcasing the importance of research and innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…